2m 2m 2m 2m 2m 2m 2m
Repligen (RGEN)
NASDAQ
$172.75-$1.23 (-0.71%)
Price as of Nov 11, 2026 7:55 PM EST- $11.1BMarket Cap
- 13.39%1-Year Change
- Medical Instruments & SuppliesIndustry
Repligen (RGEN)
$172.75-$1.23 (-0.71%)
RGEN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $173.98 | ||
Change | -$4.96 (-2.77%) | ||
Open | $176.76 | ||
High | $178.38 | ||
Low | $173.85 | ||
Previous Close | $178.94 | ||
Volume | 678,645 | ||
30-Day Average Volume | 1,306,560 | ||
1-Week Change | -2.41% | ||
1-Month Change | 0.06% | ||
1-Year Change | 13.39% | ||
3-Year Change | 17.90% | ||
5-Year Change | -34.02% | ||
Fundamentals | |||
Shares Outstanding | 63.9M | ||
Total Assets | $2.9B | ||
Market Cap | $11.1B | ||
Enterprise Value | $11.0B | ||
Period: QTR TTM FY | |||
Revenue | $209.3M | ||
Net Income | -$38.4M | ||
Free Cash Flow | $38.2M | ||
EBIT | -$20.8M | ||
EBITDA | -$1.6M | ||
Net Working Capital | $1.1B | ||
EPS | -$0.68 | ||
Enterprise Value/EBITDA | -6,714 | ||
Enterprise Value/Revenue | 52 | ||
P/B | 5 | ||
P/E | -256 | ||
PEG | 0 | ||
Price/Free Cash Flow | 292 | ||
Price/Operating Cash Flow | 258 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue